In addition, it has been demonstrated that a reduction of endogenous Tau ameliorates β-amyloid-induced deficits in AD (Rapoport et al., 2002; Santacruz et al., 2005; Roberson et al., 2007; Shipton et al., 2011). Here, MAPT is linked to Alzheimer disease.